Trial Profile
A Phase 1, Single Centre, Open Label, Two-period Study in Healthy Volunteers to Determine the Effect of PBT2 on the Pharmacokinetics of Caffeine
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs PBT 2 (Primary) ; Caffeine
- Indications Alzheimer's disease; Huntington's disease
- Focus Pharmacokinetics
- Sponsors Alterity Therapeutics
- 31 Jul 2014 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
- 23 Apr 2014 New trial record